The use of dostarlimab, a safe and efficient monotherapy in MSI-H rectal cancer patients, an alternative to surgery

Immunotherapy, Ahead of Print.

Source: Immunotherapy - May 4, 2023 Category: Allergy & Immunology Authors: Yara Baz Maria Rassam Elsa Rhayem Joseph Zouein Joseph Gharios Hampig Raphael Kourie Source Type: research